Income Tax Expense (Benefit) of ImmunoGen, Inc. from 30 Jun 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ImmunoGen, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2010 to 30 Sep 2023.
  • ImmunoGen, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2023 was $1,166,000.
  • ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2022 was $1,218,000.
  • ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.
  • ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

ImmunoGen, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $1,166,000 01 Jul 2023 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $877,000 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2023 2023 Q2
Q4 2011 $0 01 Oct 2011 31 Dec 2011 10-Q 31 Jan 2012 2012 Q2

ImmunoGen, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,218,000 +$1,218,000 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 $0 $0 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $0 $0 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $0 $0 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $0 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020 2019 FY
2010 $265,000 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.